Kamada (KMDA) Net Margin (2012 - 2026)
Kamada (KMDA) posted quarterly Net Margin of 14.7% for Q1 2026, down 634.0% year-on-year from 2.75% in Q1 2025, and up 11.2% on a QoQ basis from 13.22% in Q4 2025.
Kamada (KMDA) Net Margin (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Net Margin for 15 consecutive years, with 14.7% the latest figure, recorded in Q1 2026.
- Quarterly Net Margin fell 634.0% year-over-year to 14.7% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.04% (up 1.0% YoY) and the FY2025 annual result came in at 14.82%, up 723.0% from the prior year.
- Net Margin advanced to 14.7% in Q1 2026 per KMDA's latest filing, from 13.22% in the prior quarter.
- Over the last five years, Net Margin for KMDA reached as high as 21.04% in Q1 2025 and fell as low as 0.0% in Q1 2023.
- A 5-year average of 8.32% and a median of 7.15% in 2022 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin surged 2246 bps — and 2023, when it slumped 1189 bps.
- Year by year, Net Margin stood at 7.15% in 2022, then surged by 92 bps to 13.7% in 2023, then plunged by 79 bps to 2.85% in 2024, then jumped by 365 bps to 13.22% in 2025, then rose by 11 bps to 14.7% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 14.7%, 13.22%, and 15.82% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 14.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.70% |
| Dec 31, 2025 | 13.22% |
| Sep 30, 2025 | 15.82% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 21.04% |
| Dec 31, 2024 | 2.85% |
| Sep 30, 2024 | 9.66% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 6.66% |
| Dec 31, 2023 | 13.70% |
| Sep 30, 2023 | 8.50% |
| Jun 30, 2023 | 4.84% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 7.15% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 16.73% |
| Mar 31, 2022 | 6.51% |
| Dec 31, 2021 | -15.31% |
| Sep 30, 2021 | 3.77% |
| Jun 30, 2021 | 3.98% |